Atlas Trials

Meningococcal ACWY Disease

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Meningococcal ACWY Disease

RecordFirmDate
A Study To Evaluate A Booster Dose Of Menacwy-tt Vaccine Administered 10 Years After Healthy Subjects Aged 11-17 Years Received Either Menacwy-tt Vaccine (Nimenrix(Registered)) Or Mencevax Acwy(Registered). (NCT03189745)Pfizer2017-08-01

Track Meningococcal ACWY Disease automatically

Every clearance here is in the API, with alerts when new ones post.